Wegovy weight-loss drug OK'd in China
9 months ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people in 2022, according to the country's National Health Commission. The report noted that the approval for Wegovy comes as the patent on the drug's active ingredient, semaglutide, is set to expire in China in 2026 and as competition from domestic drugmakers increases. Clinical trial records show around 15 generic versions of Wegovy and Ozempic — also made by Novo Nordisk and which contains the same semaglutide active ingredient as Wegovy — are being developed in China, Reuters reported last month. Eli Lilly's blockbuster diabetes drug Tirzepatide won approval in China last month, while its Zepbound obesity drug that shares the same active ingredient is still under review, the Journal reported.

China Chinese Drug Novo Nordisk Wegovy Ozempic  according  wegovy  ozempic  semaglutide  drug  obesity  okd  novo  nordisk  weightloss  china  reported

History of this topic

Eli Lilly’s weight-loss drug Mounjaro comes to India, eyes big market with increasing obesity and diabetes risk
Trending News
1 week, 2 days ago

Eli Lilly’s weight-loss drug Mounjaro comes to India, eyes big market with increasing obesity and diabetes risk

Live Mint  

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, March 20, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with high rates of obesity and diabetes. According to global media reports, US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with …

Medicine, not miracle drug: Top pharma executive busts weight-loss myths
3 weeks, 2 days ago

Medicine, not miracle drug: Top pharma executive busts weight-loss myths

India Today  

Weight-loss drug is not a magic pill, Novo Nordisk India’s Vikrant Shrotriya said while speaking at a session on obesity treatments at the India Today Conclave 2025. Shrotriya, who is also the Corporate Vice President of Novo Nordisk India, highlighted the importance of making lifestyle and diet changes to combat obesity as he pushed back against tags such as "miracle …

Why don't celebrities admit to taking weight-loss medicine? Expert answers at India Today Conclave
3 weeks, 2 days ago

Why don't celebrities admit to taking weight-loss medicine? Expert answers at India Today Conclave

India Today  

Many celebrities who have undergone dramatic transformations have avoided admitting to using weight loss drugs, despite its growing popularity. Addressing this reluctance, Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, said, "They just want to pat their back that they have fantastic genes. Watch the full India Today Conclave 2025 here During a session on obesity …

Ozempic maker Novo Nordisk prepared to enter India despite patent expiry, generic competition
3 weeks, 2 days ago

Ozempic maker Novo Nordisk prepared to enter India despite patent expiry, generic competition

Live Mint  

Danish drugmaker Novo Nordisk is prepared to enter the Indian market and other markets with its blockbuster drug Ozempic, despite losing patent exclusivity early next year. “Even as we face patent expiration for Semaglutide, we’ll probably still launch the product in markets and volume growth, and to do that we need to have a very large manufacturing footprint,” Lars Fruergaard …

Higher dose and even cheaper: New vials of popular weight-loss drug released
1 month ago

Higher dose and even cheaper: New vials of popular weight-loss drug released

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Ozempic play: Mankind Pharma in the fray for weight-loss drugs
1 month ago

Ozempic play: Mankind Pharma in the fray for weight-loss drugs

Live Mint  

Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off-patent early next year. “Obesity is the market everybody wants to look at, it's a very, very big market opening up…we are no exception to that," Atish Majumdar, senior president at Mankind …

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
1 month, 1 week ago

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Associated Press  

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday. Compounding pharmacies and other entities that have been allowed to make and distribute off-brand copies of the drugs during the shortage will have to wind down …

New drug for type 2 diabetes to be offered
1 month, 2 weeks ago

New drug for type 2 diabetes to be offered

China Daily  

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ultra-long-acting GLP-1 injection has been approved for market by China's National Medical Products Administration for the treatment of type 2 diabetes in adults. "Our innovative injection boasts an average half-life of up to 204 hours in the human body, making it the longest-lasting GLP-1 drug on the global …

Wegovy: sales of weight loss injection more than double
1 month, 3 weeks ago

Wegovy: sales of weight loss injection more than double

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Elli Lilly’s weight loss drug to be covered in Medicare insurance in US for THIS treatment - all you need to know
2 months, 2 weeks ago

Elli Lilly’s weight loss drug to be covered in Medicare insurance in US for THIS treatment - all you need to know

Live Mint  

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment. The Wednesday statement from the Centers for Medicare & Medicaid Services comes after Zepbound in December became the first drug approved in the U.S. for sleep apnea, strengthening its case for coverage as Medicare …

Why the Obesity Drug Revolution Is a Work in Progress
2 months, 4 weeks ago

Why the Obesity Drug Revolution Is a Work in Progress

Bloomberg  

A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially the companies that developed them, Eli Lilly & Co. and Novo Nordisk A/S. It also remains unclear whether pharma companies can actually deliver on the promise of even better weight-loss drugs — part …

It’s getting harder to claim success with weight reduction drugs
2 months, 4 weeks ago

It’s getting harder to claim success with weight reduction drugs

Live Mint  

In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock price to fall by as much as 29%. CagriSema is a combination of the GLP-1 agonist semaglutide, the ingredient found in Novo’s Ozempic and Wegovy, and cagrilintide, …

Junk food companies 'freaking out' as people on weight-loss meds eat better: columnist
2 months, 4 weeks ago

Junk food companies 'freaking out' as people on weight-loss meds eat better: columnist

Raw Story  

Junk food companies are starting to get nervous over how many Americans use GLP-1 medications to lose weight. Washington Post columnist Catherine Rampell walked through shocking details of the economic impact of drugs like Wegovy and Ozempic cited in a new study by Cornell University and Numerator. Meanwhile, the Danish pharmaceutical company Novo Nordisk, which makes Ozempic and Wegovy, made …

MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses they could treat
2 months, 4 weeks ago

MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses they could treat

Daily Mail  

Imagine if you could eat your fill on Christmas Day then dial down your appetite for January. The past year has seen the rise of myriad weight-loss drugs that are getting better and achieving results where decades of hectoring and dieting have failed – in yet another miracle of biomedical science. Yes cancer, dementia and anxiety are on the rampage; …

Competition will make weight-loss drugs better, cheaper and bigger
3 months ago

Competition will make weight-loss drugs better, cheaper and bigger

Live Mint  

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Patrik Jonsson, head of the division at Eli Lilly that is responsible for weight-loss drugs, says that the level of competition is something he has never experienced before. In China nearly half …

Novo Nordisk’s share plunges 19.5% post release of weight loss drug CagriSema’s trial results
3 months, 1 week ago

Novo Nordisk’s share plunges 19.5% post release of weight loss drug CagriSema’s trial results

Live Mint  

The experimental next-generation obesity drug CagriSema helped overweight patients cut their weight by 22.7 percent in a late-stage trial, Reuters quoted Novo Nordisk as saying on Friday, adding the results were 25 percent they had expected. The new findings from the drug candidate deals a blow to the Danish drugmaker's ambitions for a successor to its popular Wegovy more powerful …

Consultations for obesity drug prescriptions are way up over 2023, survey finds
3 months, 2 weeks ago

Consultations for obesity drug prescriptions are way up over 2023, survey finds

NPR  

Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
3 months, 3 weeks ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
3 months, 3 weeks ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Zepbound tops Wegovy for weight loss in Eli Lilly study
3 months, 3 weeks ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press  

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
3 months, 3 weeks ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial
3 months, 3 weeks ago

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A rival drug company is celebrating results claiming its drug helps …

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
3 months, 3 weeks ago

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Live Mint  

* Novo Nordisk India team fears losing competitive edge to Eli Lilly * Novo's Wegovy and Lilly's Mounjaro are GLP-1 receptor agonists * India's obesity rates rising, increasing demand for weight-loss drugs By Leroy Leo and Rishika Sadam BENGALURU/HYDERABAD, Dec 3 - Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of …

Eli Lilly and Novo Nordisk’s obesity moat just got stronger
3 months, 4 weeks ago

Eli Lilly and Novo Nordisk’s obesity moat just got stronger

Live Mint  

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. Not only did MariTide fail to outperform Lilly’s Zepbound, but both Lilly and Novo also have next-generation medications under development, with promising data showing even more impressive weight loss results. “A 20% weight loss would have been best-in-class if …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
4 months ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Trending News
4 months ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Associated Press  

WASHINGTON — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound …

What happens when Ozempic and Wegovy don’t work?
4 months ago

What happens when Ozempic and Wegovy don’t work?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
4 months, 1 week ago

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon  

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …

Novo Nordisk's obesity drug goes on sale in China
4 months, 1 week ago

Novo Nordisk's obesity drug goes on sale in China

Deccan Chronicle  

Beijing: Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity. A Novo Nordisk spokesperson confirmed to AFP on Tuesday that the drug was "now available in China" for the treatment of adults with obesity and those overweight with at least …

Wegovy in China: Novo Nordisk launches weight-loss drug at cheaper price, eyes 180 mn people with obesity
4 months, 1 week ago

Wegovy in China: Novo Nordisk launches weight-loss drug at cheaper price, eyes 180 mn people with obesity

Firstpost  

Novo Nordisk gained approval for Wegovy in China in June, and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo Nordisk gained approval …

Weight-loss drug Wegovy launched in China
4 months, 1 week ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
4 months, 1 week ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Makers of Wegovy and Ozempic issue warning over deadly weight-loss copycats
Trending News
4 months, 3 weeks ago

Makers of Wegovy and Ozempic issue warning over deadly weight-loss copycats

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Novo Nordisk’s popular weight-loss injection Wegovy and diabetes drug …

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares
4 months, 3 weeks ago

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares

Live Mint  

-- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field. Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could be a reality soon: People who took 100-milligram doses …

Big Pharma’s obesity bonanza faces new tests
4 months, 3 weeks ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
4 months, 4 weeks ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
5 months, 3 weeks ago

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The United …

Eli Lilly sanguine about China market
7 months ago

Eli Lilly sanguine about China market

China Daily  

Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. Eli Lilly said people who are overweight or those who face obesity issues face social stigma every day and that the drugmaker aims to improve the quality of their lives. "The commonly held view that their weight is somehow their own …

Eli Lilly sanguine about China market
7 months ago

Eli Lilly sanguine about China market

China Daily  

Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. Eli Lilly said people who are overweight or those who face obesity issues face social stigma every day and that the drugmaker aims to improve the quality of their lives. "The commonly held view that their weight is somehow their own …

Eli Lilly is gaining on Novo Nordisk in the obesity race
7 months, 2 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint  

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Wegovy: Ozempic sister drug to be sold in Australia within days
7 months, 4 weeks ago

Wegovy: Ozempic sister drug to be sold in Australia within days

Daily Mail  

A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days. Like Ozempic, the drug is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes. In May the Australian government …

The science of tirzepatide, touted as a game-changing weight loss drug
8 months ago

The science of tirzepatide, touted as a game-changing weight loss drug

Hindustan Times  

Indians will soon have access to a new drug that targets obesity and diabetes, two diseases, which are widely prevalent among our population. They stimulate the release of insulin, and help increase insulin sensitivity in adipose and skeletal tissue,” said RNV Krishna Deepak, a computational structural biologist at Azim Premji University, Bengaluru. “Tirzepatide has received marketing authorisation for type-2 diabetes …

Don't insure use of Wegovy slimming drug, health institute says
8 months, 1 week ago

Don't insure use of Wegovy slimming drug, health institute says

Dutch News  

Slimming drug Wegovy should not be included in the basic insurance package because its long-term health benefits are unclear and it will also boost costs, the Dutch healthcare institute has said in recommendations to health minister Fleur Agema. Pharmaceutical company Novo Nordisk filed a request for Wegovy to be admitted to the basic insurance package last year. A majority of …

Don't insure use of Wegovy slimming drug, health institute says
8 months, 1 week ago

Don't insure use of Wegovy slimming drug, health institute says

Dutch News  

Slimming drug Wegovy should not be included in the basic insurance package because its long-term health benefits are unclear and it will also boost costs, the Dutch healthcare institute has said in recommendations to health minister Fleur Agema. Pharmaceutical company Novo Nordisk filed a request for Wegovy to be admitted to the basic insurance package last year. A majority of …

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
8 months, 2 weeks ago

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Firstpost  

Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. Here’s what we know about this ‘game-changing’ medication A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Last week, the apex drug regulator’s, …

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results
8 months, 2 weeks ago

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Wegovy weight-loss drug OK'd in China
9 months ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

In China, weight-loss drugs are becoming big business
9 months, 3 weeks ago

In China, weight-loss drugs are becoming big business

Al Jazeera  

Chinese pharmaceutical companies are racing to roll out weight-loss drugs amid the popularity of Ozempic. Ozempic was approved in China to treat diabetes in 2021, but it has been its anti-obesity ingredient, semaglutide, that has fuelled demand for what many Chinese refer to as the “internet celebrity weight-loss drug”. “Weight-loss drugs fall within a market with massive growth potential in …

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says
10 months, 4 weeks ago

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says

CNN  

CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …

Discover Related